- pause slideshow
Rare but not forgotten: why drug appraisal methods must be updated to consider treatments for rare diseasesSubscription
The UK government needs to adapt its drug and technology appraisal methods to prevent patients with rare diseases being left out in the cold.
As pharmacy contractors in England suffer budget cuts and their leaders instigate legal action, Northern Ireland pharmacy contractor Terry Maguire argues why this might not be a good idea and what English contractors might learn from their Celtic cousins.
Evidence is emerging that biocides and heavy metals all contribute to the growing problem of antimicrobial resistance.
Previous court cases concerning informed consent of treatment have raised questions about what consent means in relation to pharmacists, medicines and prescribing.
While the implications of Brexit on drug regulation in the UK are largely unknown, the government needs to consider its options quickly to avoid delaying public access to important medicine.
The new urgent medicine supply scheme from NHS England requires more thought and revision.
Your RPS needs youSubscription
Show your passion and dedication to pharmacy by putting yourself forward for this year’s RPS national pharmacy board elections.
Recommendations made in Murray’s review for community pharmacy will not be simple to implementSubscription
Practical challenges, including building closer relationships with GPs, will need to be overcome if the recommendations in the Murray review on community pharmacy are to be implemented successfully.
Limiting HIV resistance must not be neglected in an era where we continue to see breakthroughs in treatment for the infection once labelled a death sentence.
Cholesterol-lowering statin therapy for healthy people is not as simple as 'yes' or 'no'Subscription
Recent reports of large trials extolling the virtues of statins have led many to believe that low-risk patients should take them, but an examination of the evidence provides food for thought.
There are a number of factors that contribute to patients’ fear and reluctance to take osteoporosis drugs, leaving them at increased risk of fractures.
Research suggests no substantive outcome differences between the use of originator biologics and their biosimilar counterparts Source: Shutterstock.com
Q&A: How to ensure access to essential medicines for those in low and middle-income countriesSubscription
Andy Gray and Hans Hogerzeil, co-chairs of the The Lancet Commission on Essential Medicines, discuss the analysis on the cost of providing essential medicines to people in low and middle-income countries.
Shanelle Hall from UNICEF discusses the breakthrough pentavalent vaccine three-year tender with six vaccine suppliers.
The author of the 2013 report which looked at patient safety in the NHS after the Mid Staffordshire Hospital scandal speaks to Jenny Bryan to share his thoughts on whether progress has been made.
Six candidates in the race to be director-general of the World Health Organization outline their priorities and vision for global health.
Comprehensive drug reference resource from the American Society of Health-System PharmacistsSubscription
This new edition of the popular drug reference includes oncology drugs approved under the US Food and Drug Administration’s accelerated approval programme.
The war with body fatSubscription
The secret life of fat, by Sylvia Tara
Drug dealer, MD, by Anna Lembke
The acid watcher diet: a 28-day reflux prevention and healing programme, by Jonathan Aviv
It’s RPS national board election time againSubscription
Alex MacKinnon, interim chief executive of the Royal Pharmaceutical Society, makes a plea for members to use their vote in the 2017 national board elections.
The Royal Pharmaceutical Society (RPS) Welsh Pharmacy Board launched its manifesto in November 2015. Mair Davies, director for RPS Wales, talks to Julia Robinson about progress made since the launch, and her objectives for 2017 and beyond.
New RPS director for England, Robbie Turner, tells Julia Robinson about his plans for 2017 and how he hopes his experience as chief executive of Community Pharmacy West Yorkshire will help him achieve his goals.
Alex MacKinnon, director for the Scotland at the Royal Pharmaceutical Society (RPS), tells Julia Robinson what 2017 will mean for pharmacists in Scotland and how RPS Scotland plans to embrace new opportunities on behalf of the profession.
The recent letters about The Pharmaceutical Journal (Pharmaceutical Journal 2017;298:99) raise two issues: the organisational structure of the journal and its editorial content. They are separate ...
Members of the Royal Pharmaceutical Society national pharmacy boards should be capable professionals who are reputable and are willing to make changes for the benefit for the profession. We need our representatives on the boards to make a positive impact on our profession and perspective.
Pharmacists working together to alleviate stressSubscription
Pharmacist front-line working is increasingly stressful. Unfortunately there are a multitude of external pressures that we have little or no control over. But I believe there is one area we can control: how we work with our fellow pharmacists.
Pharmacy, alchemy and endless possibilitiesSubscription
“This is alchemy, and this is the office of Vulcan; he is the apothecary and chemist of the medicine.”
Shane Kailla describes his experience of pharmacy practice in Shanghai, China, during his 2016 summer placement.
We are calling for article submissions that highlight best practice in relation to the management of long-term conditions.
The reported shortage of a popular throat mixture has sent panic across the entertainment industry because of its popularity with actors, singers and performers.
Baguiasri Mandane shares her experience and what she learnt on her oncology rotation at University Hospitals of Leicester NHS Trust
Thomas Geoffrey Booth (1928-2016)Subscription
Thomas Geoffrey Booth, past president of the Royal Pharmaceutical Society, founded the UK’s first department of pharmacy practice.
Frank P Palopoli (1922–2016) Subscription
The scientist who discovered the fertility drug clomifene was known as a modest man who mentored his staff.
Kirit Patel (1949-2016)Subscription
A self-made man who started out wanting to own a shop to support his family, Kirit Patel’s lifetime achievements are inspirational.
Philip Majerus (1936-2016)Subscription
Majerus was one of the first researchers who discovered the benefits of low dose aspirin in preventing heart attacks and strokes.